PharmTech LCGC Sciex Webinar 11.10
|Articles|January 29, 2009

Waters reports financial results

Waters reported fourth quarter 2008 sales of $418 million, a decrease of 4% from sales of $437 million in the fourth quarter of 2007. In the quarter, the effects of foreign currency translation were responsible for the reduced sales growth rate.

Waters reported fourth quarter 2008 sales of $418 million, a decrease of 4% from sales of $437 million in the fourth quarter of 2007. In the quarter, the effects of foreign currency translation were responsible for the reduced sales growth rate. Thus on a currency neutral basis, sales were approximately flat with the prior year's quarterly sales.

For the full year, sales for the company were $1.58 billion, an increase of 7% over sales of $1.47 billion in 2007. Foreign currency translation contributed 2% to the reported sales growth rate.

Commenting on the company's performance, Douglas Berthiaume, chairman, president and chief executive officer said, "Overall, 2008 was a very successful year for Waters. The challenges that we faced in the fourth quarter reflect the tougher economic environment that we are likely to continue to encounter in 2009. We are confident that we can manage our business effectively through this difficult period and we remain committed to new product research and customer support programmes to ensure our long term growth and continued strong market position."

Waters announced the fourth quarter 2008 financial results via a conference call. To listen to the call, connect to www.waters.com, choose "Investor Relations" and click on the "Live Webcast". A replay will be available until 3 February 2009.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.